These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 2470148

  • 1. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines.
    Poli G, Orenstein JM, Kinter A, Folks TM, Fauci AS.
    Science; 1989 May 05; 244(4904):575-7. PubMed ID: 2470148
    [Abstract] [Full Text] [Related]

  • 2. Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells.
    Biswas P, Poli G, Kinter AL, Justement JS, Stanley SK, Maury WJ, Bressler P, Orenstein JM, Fauci AS.
    J Exp Med; 1992 Sep 01; 176(3):739-50. PubMed ID: 1512539
    [Abstract] [Full Text] [Related]

  • 3. Alpha interferon suppresses virion but not soluble human immunodeficiency virus antigen production in chronically infected T-lymphocytic cells.
    Fernie BF, Poli G, Fauci AS.
    J Virol; 1991 Jul 01; 65(7):3968-71. PubMed ID: 1710293
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of human immunodeficiency virus type 1 morphogenesis in T cells by alpha interferon.
    Smith MS, Thresher RJ, Pagano JS.
    Antimicrob Agents Chemother; 1991 Jan 01; 35(1):62-7. PubMed ID: 1707604
    [Abstract] [Full Text] [Related]

  • 5. Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage.
    Poli G, Kinter AL, Justement JS, Bressler P, Kehrl JH, Fauci AS.
    J Exp Med; 1991 Mar 01; 173(3):589-97. PubMed ID: 1705278
    [Abstract] [Full Text] [Related]

  • 6. Loss of infectivity by progeny virus from alpha interferon-treated human immunodeficiency virus type 1-infected T cells is associated with defective assembly of envelope gp120.
    Hansen BD, Nara PL, Maheshwari RK, Sidhu GS, Bernbaum JG, Hoekzema D, Meltzer MS, Gendelman HE.
    J Virol; 1992 Dec 01; 66(12):7543-8. PubMed ID: 1279206
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of HIV-1 transmission by interferon and 3'-azido-3'-deoxythymidine during de novo infection of promonocytic cells.
    Dubreuil M, Sportza L, D'Addario M, Lacoste J, Rooke R, Wainberg MA, Hiscott J.
    Virology; 1990 Nov 01; 179(1):388-94. PubMed ID: 1699354
    [Abstract] [Full Text] [Related]

  • 8. Soluble tumor necrosis factor receptors inhibit phorbol myristate acetate and cytokine-induced HIV-1 expression chronically infected U1 cells.
    Granowitz EV, Saget BM, Angel JB, Wang MZ, Wang A, Dinarello CA, Skolnik PR.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr 15; 11(5):430-7. PubMed ID: 8605587
    [Abstract] [Full Text] [Related]

  • 9. A platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cells.
    Weissman D, Poli G, Bousseau A, Fauci AS.
    Proc Natl Acad Sci U S A; 1993 Mar 15; 90(6):2537-41. PubMed ID: 7681601
    [Abstract] [Full Text] [Related]

  • 10. Synergistic drug interactions of an HIV-1 protease inhibitor with AZT in different in vitro models of HIV-1 infection.
    Lambert DM, Bartus H, Fernandez AV, Bratby-Anders C, Leary JJ, Dreyer GB, Metcalf BW, Petteway SR.
    Antiviral Res; 1993 Aug 15; 21(4):327-42. PubMed ID: 7692816
    [Abstract] [Full Text] [Related]

  • 11. Two-drug combinations of zidovudine, didanosine, and recombinant interferon-alpha A inhibit replication of zidovudine-resistant human immunodeficiency virus type 1 synergistically in vitro.
    Johnson VA, Merrill DP, Videler JA, Chou TC, Byington RE, Eron JJ, D'Aquila RT, Hirsch MS.
    J Infect Dis; 1991 Oct 15; 164(4):646-55. PubMed ID: 1716649
    [Abstract] [Full Text] [Related]

  • 12. Valproic acid reduces the intracellular level of glutathione and stimulates human immunodeficiency virus.
    Simon G, Moog C, Obert G.
    Chem Biol Interact; 1994 Jun 15; 91(2-3):111-21. PubMed ID: 7514959
    [Abstract] [Full Text] [Related]

  • 13. Analysis of Tat function in human immunodeficiency virus type 1-infected low-level-expression cell lines U1 and ACH-2.
    Cannon P, Kim SH, Ulich C, Kim S.
    J Virol; 1994 Mar 15; 68(3):1993-7. PubMed ID: 8107261
    [Abstract] [Full Text] [Related]

  • 14. Restriction of HIV replication in infected T cells and monocytes by interferon-alpha.
    Gendelman HE, Baca L, Turpin JA, Kalter DC, Hansen BD, Orenstein JM, Friedman RM, Meltzer MS.
    AIDS Res Hum Retroviruses; 1990 Aug 15; 6(8):1045-9. PubMed ID: 2121192
    [Abstract] [Full Text] [Related]

  • 15. AZT (zidovudine) may act postintegrationally to inhibit generation of HIV-1 progeny virus in chronically infected cells.
    Rooke R, Tremblay M, Wainberg MA.
    Virology; 1990 May 15; 176(1):205-15. PubMed ID: 1691885
    [Abstract] [Full Text] [Related]

  • 16. Synergistic stimulatory effects of tumour necrosis factor alpha and interferon gamma on replication of human immunodeficiency virus type 1 and on apoptosis of HIV-1-infected host cells.
    Han X, Becker K, Degen HJ, Jablonowski H, Strohmeyer G.
    Eur J Clin Invest; 1996 Apr 15; 26(4):286-92. PubMed ID: 8732485
    [Abstract] [Full Text] [Related]

  • 17. Recombinant human interferon-beta suppresses the replication of HIV and acts synergistically with AZT.
    Williams GJ, Colby CB.
    J Interferon Res; 1989 Dec 15; 9(6):709-18. PubMed ID: 2514233
    [Abstract] [Full Text] [Related]

  • 18. Three-drug synergistic inhibition of HIV-1 replication in vitro by zidovudine, recombinant soluble CD4, and recombinant interferon-alpha A.
    Johnson VA, Barlow MA, Merrill DP, Chou TC, Hirsch MS.
    J Infect Dis; 1990 Jun 15; 161(6):1059-67. PubMed ID: 2345291
    [Abstract] [Full Text] [Related]

  • 19. Interferon-alpha treatment leads to accumulation of virus particles on the surface of cells persistently infected with the human immunodeficiency virus type 1.
    Yasuda Y, Miyake S, Kato S, Kita M, Kishida T, Kimura T, Ikuta K.
    J Acquir Immune Defic Syndr (1988); 1990 Jun 15; 3(11):1046-51. PubMed ID: 2213506
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of HIV-1 latency reactivation by dehydroepiandrosterone (DHEA) and an analog of DHEA.
    Yang JY, Schwartz A, Henderson EE.
    AIDS Res Hum Retroviruses; 1993 Aug 15; 9(8):747-54. PubMed ID: 7692906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.